Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcadia Biosciences (RKDA) Consolidated Net Income (2016 - 2024)

Arcadia Biosciences filings provide 11 years of Consolidated Net Income readings, the most recent being -$27000.0 for Q4 2024.

  • On a quarterly basis, Consolidated Net Income rose 99.63% to -$27000.0 in Q4 2024 year-over-year; TTM through Sep 2025 was -$27000.0, a 99.73% increase, with the full-year FY2024 number at -$2.7 million, up 65.28% from a year prior.
  • Consolidated Net Income hit -$27000.0 in Q4 2024 for Arcadia Biosciences, up from -$430000.0 in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $14.2 million in Q4 2020 to a low of -$7.6 million in Q3 2020.
  • Median Consolidated Net Income over the past 5 years was -$1.3 million (2022), compared with a mean of -$1.4 million.
  • Biggest five-year swings in Consolidated Net Income: surged 347.62% in 2020 and later plummeted 715.47% in 2024.
  • Arcadia Biosciences' Consolidated Net Income stood at $14.2 million in 2020, then plummeted by 60.68% to $5.6 million in 2021, then crashed by 120.53% to -$1.1 million in 2022, then tumbled by 531.1% to -$7.2 million in 2023, then soared by 99.63% to -$27000.0 in 2024.
  • The last three reported values for Consolidated Net Income were -$27000.0 (Q4 2024), -$430000.0 (Q3 2024), and -$789000.0 (Q2 2024) per Business Quant data.